Olga Vampertzi

Dr. Olga Vampertzi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
OVOlga Vampertzi
Olga Vampertzi
KPKYRIAKI PAPADOPOULOU-LEGBELOU
KYRIAKI PAPADOPOULOU-LEGBELOU
ATAreti Triantafyllou
Areti Triantafyllou
SDStella Douma
Stella Douma
EPEfimia Papadopoulou-Alataki
Efimia Papadopoulou-Alataki

1 October 2016
Verified
Journal Article
Closed access
EPE Papadopoulou-Alataki
E Papadopoulou-Alataki
ACA Chatziavramidis
A Chatziavramidis
OVOlga Vampertzi
Olga Vampertzi
SAS Alataki
S Alataki
IKI Konstantinidis
I Konstantinidis

5 November 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
OVOlga Vampertzi
Olga Vampertzi
KPKYRIAKI PAPADOPOULOU-LEGBELOU
KYRIAKI PAPADOPOULOU-LEGBELOU
ATAreti Triantafyllou
Areti Triantafyllou
NKNikolaos Koletsos
Nikolaos Koletsos
SASofia Alataki
Sofia Alataki
EPEfimia Papadopoulou-Alataki
Efimia Papadopoulou-Alataki

27 September 2018 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
OVOlga Vampertzi
Olga Vampertzi
EDEfterpi Dalpa
Efterpi Dalpa
TVTheofanis Vavilis
Theofanis Vavilis
DTDespoina Tramma
Despoina Tramma
Syringomyelia is the development of a fluid-filled cavity or syrinx within the spinal cord that can cause loss of sensation and muscle spasticity. Guillain-Barre syndrome (GBS) is a postinfection autoimmune disease, classified as an acute polyneuropathy. This report describes the emergency admission of a 6-year-old girl presenting with sudden pallor and pain in both lower limbs. The patient’s reflexes were normal, as were the results of her sonography, radiography and biochemical tests; however, spinal MRI revealed extensive compartmentalised syringomyelia extending from C2 to T3. A sensory and motor nerve conduction study revealed a demyelinating type motor polyneuropathy which, along with positiveMycoplasma pneumoniaetest, was suggestive of GBS. Intravenous immunoglobulin infusion showed excellent results. In conclusion, we report a rare paediatric case of syringomyelia coexisting with GBS. It is important to bear in mind the possibility of other coexisting diseases even if MRI reveals definitive characteristics of another condition.

1 February 2026 in Cureus
Verified
Journal Article
Open access
OVOlga Vampertzi
Olga Vampertzi
EVEleni Vouxinou
Eleni Vouxinou
AMAsimina Mataftsi
Asimina Mataftsi
FGFotini Goutsaridou
Fotini Goutsaridou
MFMaria Fotoulaki
Maria Fotoulaki
DZDimitrios Zafeiriou
Dimitrios Zafeiriou
Idiopathic intracranial hypertension (IIH) is a rare neurological syndrome characterized by increased intracranial pressure (>28 cm H₂O in children), in the absence of intracranial space-occupying lesions, and with normal cerebrospinal fluid (CSF) composition. Optic perineuritis (OPN) is an orbital inflammatory disease confined to the optic nerve sheath. We report a case of concurrent IIH and bilateral OPN in a previously healthy child. A 13-year-old male, with normal body mass index, presented with diplopia, visual blurriness without ocular pain, and occipital headache. Neurological examination was notable only for right sixth nerve palsy. Ophthalmological assessment revealed bilateral papilledema. Brain and spinal cord magnetic resonance imaging (MRI) and computed tomography (CT) scans demonstrated bilateral optic nerve perineuritis. Lumbar puncture showed an opening pressure of 98 cm H₂O, with normal CSF composition. The patient was treated with acetazolamide and corticosteroids, resulting in marked clinical improvement and complete restoration of vision at two-month follow-up. The concurrent occurrence of IIH and bilateral OPN is extremely rare, particularly in pediatric patients. To our knowledge, this is the first reported case in a child. Recognition of this dual pathology is essential for timely diagnosis and effective treatment.

27 June 2026 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Open access
OVOlga Vampertzi
Olga Vampertzi
TVTheofanis Vavilis
Theofanis Vavilis
AZANDROULA ZELILIDOU
ANDROULA ZELILIDOU
EVEuthymia Vargiami
Euthymia Vargiami
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a distinct immune-mediated demyelinating central nervous system disorder, frequently presenting as optic neuritis in children and adolescents. Conversely, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) is an astrocytopathy characterized by more severe relapses and greater residual visual impairment. This scoping review, conducted according to PRISMA-ScR and JBI methodology, mapped evidence from 23 studies identified across PubMed and Scopus over the last decade. The objective was to examine the epidemiology, clinical presentation, imaging, serological findings, therapeutic strategies, and visual outcomes of these conditions in pediatric populations. Results indicate that pediatric MOGAD-associated optic neuritis often presents with optic disc swelling and bilateral anterior optic nerve involvement with perineural enhancement on MRI, typically resulting in reversible visual loss. The 2023 MOGAD diagnostic criteria show high performance in children. In contrast, AQP4-associated optic neuromyelitis more commonly involves the posterior optic nerve and chiasm, leading to poorer visual outcomes. Regarding treatment, maintenance intravenous immunoglobulin (IVIG) reduces relapse risk in selected MOGAD cases, while B-cell-depleting regimens are primarily used for relapse prevention in AQP4-positive NMOSD. In conclusion, pediatric optic neuritis in MOGAD and AQP4-associated optic neuromyelitis are distinct phenotypes with differing pathobiology and therapeutic requirements. Early serological confirmation and individualized immunotherapy are crucial for preventing relapses and preserving functional vision in pediatric patients.